EUVIMEDEUVIMED entdecken
Crossref

Curcumin as a therapeutic agent in cancer: Progress, mechanism, and clinical prospects

Chirag Dhanani, Chandani Halpani

Journal of Advances in Microbiology Research · 01.07.2025 · 6 (2) · 296-304

DOI: 10.22271/micro.2025.v6.i2d.266 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Advances in Microbiology Research, online erschienen am 01.07.2025. Verfasst von Chirag Dhanani und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Curcumin, a polyphenolic molecule extracted from Curcuma longa, has emerged as a promising adjuvant and therapeutic agent in cancer treatment, demonstrating anti-inflammatory, antiproliferative, and immunomodulatory properties across several malignancies. This review carefully analyzes current progress in curcumin research, clarifies the molecular processes underlying its anticancer effects, assesses therapeutic outcomes in particular cancer types, and addresses problems in clinical translation and prospective avenues for future investigation [1-89].

Zitieren

APA

Dhanani, C., & Halpani, C. (2025). Curcumin as a therapeutic agent in cancer: Progress, mechanism, and clinical prospects. Journal of Advances in Microbiology Research, 6(2), 296-304. https://doi.org/10.22271/micro.2025.v6.i2d.266

Vancouver

Dhanani C, Halpani C. Curcumin as a therapeutic agent in cancer: Progress, mechanism, and clinical prospects. Journal of Advances in Microbiology Research. 2025;6(2):296-304. doi:10.22271/micro.2025.v6.i2d.266

BibTeX
@article{Dhanani2025,
  author = {Dhanani, Chirag and Halpani, Chandani},
  title = {Curcumin as a therapeutic agent in cancer: Progress, mechanism, and clinical prospects},
  journal = {Journal of Advances in Microbiology Research},
  year = {2025},
  volume = {6},
  number = {2},
  pages = {296--304},
  doi = {10.22271/micro.2025.v6.i2d.266}
}
Kostenlos starten →